摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ZR2002

中文名称
——
中文别名
——
英文名称
ZR2002
英文别名
N4-(3-bromophenyl)-N6-(2-chloroethyl)quinazoline-4,6-diamine;N4-(3-Bromophenyl)-N6-(2-chloroethyl)-4,6-quinazolinediamine;4-N-(3-bromophenyl)-6-N-(2-chloroethyl)quinazoline-4,6-diamine
ZR2002化学式
CAS
——
化学式
C16H14BrClN4
mdl
——
分子量
377.671
InChiKey
NPLZGCKBBUBACR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    49.8
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    2-氰基-4-硝基苯胺盐酸乙醇铁粉 、 sodium cyanoborohydride 、 氯化铵溶剂黄146 作用下, 以 甲醇 为溶剂, 生成 ZR2002
    参考文献:
    名称:
    EGFR/DNA双靶向策略治疗EGFRL858R/T790M突变肺癌的抗肿瘤活性及机制
    摘要:
    双靶点或多靶点 EGFR 抑制剂作为单一药物可以克服 EGFR 抑制剂耐药性并规避联合治疗的许多缺点。在这项工作中,设计并合成了 15 个带有氮芥或半芥部分的 4-苯胺基喹唑啉衍生物作为双 EGFR-DNA 靶向抗癌剂。目标分子的结构通过1 H NMR、13 C NMR 和 HR-MS确证,并使用 MTT 法评估其体外抗增殖活性。化合物6g成为针对突变型 H1975 细胞的最有效衍生物,IC 为50值为 1.45 μM,其效力比 Chl/Gef(苯丁酸氮芥和吉非替尼的等摩尔组合)强 4 倍。激酶抑制研究表明,6g对 EGFR L858R/T790M酶有极好的抑制作用,是吉非替尼的 8.6 倍。机理研究表明,6g以剂量依赖的方式诱导 H1975 细胞凋亡,并引起 DNA 损伤。重要的是,6g可显着抑制H1975细胞中p-EGFR及其下游p-AKT和p-ERK的表达。还进行了分子对接以深入了解EGFR
    DOI:
    10.1016/j.bioorg.2023.106510
点击查看最新优质反应信息

文献信息

  • Novel combi-molecules having EGFR and DNA targeting properties
    申请人:Jean-Claude Bertrand
    公开号:US20060003970A1
    公开(公告)日:2006-01-05
    A series of new chemical agents that demonstrate anti-tumor activity are described. The new chemical agents combine two major mechanisms of anti-tumor action. In an embodiment, the agents are capable of both inhibiting EGFR and damaging DNA while also, upon degradation, degrading to an inhibitor of EGFR and to an agent capable of damaging DNA. Moreover, a novel series of molecules capable of releasing two moles of EGFR inhibitor and a potent bi-functional alkylating agent are also described.
    描述了一系列展示抗肿瘤活性的新化学试剂。这些新化学试剂结合了两种主要的抗肿瘤作用机制。在一个实施例中,这些试剂既能够抑制EGFR又能够损伤DNA,同时,在降解时,会降解为EGFR抑制剂和能够损伤DNA的试剂。此外,还描述了一系列新颖的分子,能够释放两摩尔的EGFR抑制剂和一种强效的双功能烷基化剂。
  • Comparative analysis of the dual EGFR-DNA targeting and growth inhibitory properties of 6-mono-alkylamino- and 6,6-dialkylaminoquinazoline-based type II combi-molecules
    作者:Julie Schmitt、Elliot Goodfellow、Shanlong Huang、Christopher Williams、Izabela N.F. Gomes、Marcela N. Rosa、Rui M. Reis、Richard Yang、Hatem M. Titi、Bertrand J. Jean-Claude
    DOI:10.1016/j.ejmech.2020.112185
    日期:2020.4
    Over the past decade, we described a novel tumour targeted approach that sought to design "combimolecules" to hit two distinct targets in tumour cells. Here, to generate small combi-molecules with strong DNA damaging potential while retaining EGFR inhibitory potency, we developed the first synthetic strategy to access the 6-N, N-disubstituted quinazoline scaffold and designed JS61 to possess a nitrogen mustard function directly attached to the 6-position of the quinazoline ring. We compared its biological activity with that of structures containing either a hemi mustard or a non-alkylating substituent. Surprisingly, the results showed that JS61, while capable of inducing strong DNA damage, exhibited moderate EGFR inhibitory potency. In contrast, "combi-molecules" with no bulky substituent at the N-6 position (e.g. ZR2002 and JS84) showed stronger EGFR and growth inhibitory potency than JS61 in a panel of lung cancer cells. To rationalize these results, X-ray crystallography and molecular modeling studies were undertaken, and the data obtained indicated that bulkiness of the 6-N,N-disubstituted moieties hinder its binding to the ATP site and affects binding reversibility. (c) 2020 Published by Elsevier Masson SAS.
  • Novel Nitrogen Mustard-Armed Combi-Molecules for the Selective Targeting of Epidermal Growth Factor Receptor Overexperessing Solid Tumors:  Discovery of an Unusual Structure−Activity Relationship
    作者:Zakaria Rachid、Fouad Brahimi、Qiyu Qiu、Christopher Williams、Janet M. Hartley、John A. Hartley、Bertrand J. Jean-Claude
    DOI:10.1021/jm070144p
    日期:2007.5.1
    To enhance the potency of "combi-molecules", we designed 6a-d and 18 to release an inhibitor of EGFR TK and a bifunctional alkylator. The combi-molecules blocked EGFR TK with potency increasing with the basicity of the mustard moiety. They selectively killed cells transfected with EGFR and were potent against the DU145 prostate cancer cells. Combi-molecule 6a blocked EGFR phosphorylation in an irreversible manner, induced DNA-cross-links, and arrested the cells in mid-S.
  • Synthesis of half-mustard combi-molecules with fluorescence properties: correlation with EGFR status
    作者:Zakaria Rachid、Fouad Brahimi、Juozas Domarkas、Bertrand Jacques Jean-Claude
    DOI:10.1016/j.bmcl.2004.12.015
    日期:2005.2
    The synthesis of 6-(2-chloroethylamino)-4-anilinoquinazolines ZR2002 and ZR2003 designed to block EGFR tyrosine kinase and to damage genomic DNA is described. These compounds present fluorescence properties that permitted the quantitation of their subcellular uptake by flow cytometry. Fluorescence intensities increased with increasing levels of EGFR in a panel of isogenic and established cell lines. (C) 2004 Elsevier Ltd. All rights reserved.
  • US7879861B2
    申请人:——
    公开号:US7879861B2
    公开(公告)日:2011-02-01
查看更多